Vyvanse 40mg (Lisdexamfetamine dimesylate Capsule) 40mg

Lisdexamfetamine, the active ingredient in Vyvanse 40mg, is a prodrug that is converted into dextroamphetamine in the body. Dextroamphetamine increases the release of norepinephrine and dopamine in the brain, which are neurotransmitters that play crucial roles in attention, focus, and impulse control. This mechanism helps manage symptoms of ADHD and BED.

The dosage of Vyvanse 40mg is determined by a healthcare provider based on the individual's condition, age, and response to the medication. It is typically taken once daily in the morning. The prescriber will adjust the dose as needed, starting with a lower dose and gradually increasing it to achieve the desired therapeutic effect.

The safety of Vyvanse 40mg during pregnancy and breastfeeding has not been fully established. It is classified as a Pregnancy Category C medication, meaning that animal studies have shown adverse effects on the fetus, but there are no adequate and well-controlled studies in pregnant women. Women who are pregnant or breastfeeding should consult their healthcare provider before using Vyvanse 40mg.

To order Vyvanse 40mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will then provide pricing, availability, shipping details, and the necessary import paperwork.

Vyvanse 40mg is a prodrug stimulant, which means it is converted into an active form in the body. This can result in a more gradual onset of action and a longer duration of effect compared to other stimulant medications. It is also less likely to be abused or misused due to its prodrug nature. However, the choice of medication depends on individual patient needs and response to treatment.

Vyvanse 40mg should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F to 86°F). Keep the medication in a cool, dry place, away from moisture and heat. Ensure that the capsules are kept in their original packaging and are protected from light.

Vyvanse 40mg is administered orally, typically once daily in the morning. The capsules can be swallowed whole or opened and the contents mixed with yogurt or water and taken immediately. It is important to take Vyvanse 40mg as prescribed by a healthcare provider to achieve the best therapeutic effects and minimize the risk of side effects.

The most serious risks associated with Vyvanse 40mg include heart problems such as increased blood pressure and heart rate, psychiatric problems like new or worsening aggression, psychosis, or manic episodes, and circulation problems in fingers and toes. Patients should be monitored closely for these potential adverse effects, and any concerning symptoms should be reported to a healthcare provider immediately.

Vyvanse 40mg should not be used by individuals with serious heart problems, severe hypertension, hyperthyroidism, glaucoma, or a history of drug abuse. It is also not recommended for patients who are taking or have recently taken monoamine oxidase inhibitors (MAOIs). Women who are pregnant or breastfeeding should consult their healthcare provider before using Vyvanse 40mg.